Summary
- Current Price
- As of today, AVIR price is $6.05, down -1.63% on
- Current Price All-Time High
- AVIR price is currently -93.58% below its historical high of $94.17 set on
- Market Cap
- AVIR current market cap is $473M, up +89.27% over the past 365 days
- PE Ratio
- AVIR PE ratio is unknown
- Revenue
- AVIR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AVIR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Atea Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AVIR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ateapharma.com |
| Employees | 56 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $6.05 | ||
| Price, 1D Change | -1.63% | |
| $473M | ||
| - | ||
| - | ||
| 0.58 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.94 | ||
| EPS, 1Y Change | +2.77% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.94 | ||
| EPS Estimate | N/A | -$1.66 |
| EPS Est. Change | N/A | +14.57% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $6.05 | ||
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +65.29% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.81 | -$2.00 | -10.70% | |
| -$1.73 | -$1.94 | -12.64% | |
| -$1.66 | N/A | +14.57% | |
| -$1.26 | N/A | +35.15% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $30.79M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +107.19% | ||
| +81.14% | ||
| +89.27% | ||
| +69.80% | ||
| 0.00% | ||
| 0.00% | ||
| +2.77% | ||
| -39.54% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $6.05 | ||
| $3.50 | ||
| SMA 200 vs Price | -42.16% | |
| $4.18 | ||
| SMA 50 vs Price | -30.84% | |
| 0.58 | ||
| $0.30 | ||
| 82.21 | ||
| 63.33% | ||
| 48.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.94 | ||
| -$416.00K | ||
| - | ||
| -$180.89M | ||
| - | ||
| -$158.35M | ||
| - | ||
| -$180.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 7.82 | ||
| 7.82 | ||
| - | ||
| - | ||
| 3.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.72 | ||
| -0.95 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $275.43M | ||
| $301.83M | ||
| $315.22M | ||
| $310.99M | ||
| $39.78M | ||
| $39.78M | ||
| $843.00K | ||
| $843.00K | ||
| $12.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $158.35M | ||
| $180.47M | ||
| $416.00K | ||
| $0.00 | ||
| $416.00K | ||
| $0.00 | ||
| -$6.16M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$132.03M | ||
| $188.79M | ||
| -$25.75M | ||
| $0.00 | ||
| -$132.03M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| JP Morgan | ||
| SVB Leerink | ||
| Morgan Stanley | ||
| Morgan Stanley | ||
| JP Morgan | ||
| SVB Leerink |
Analyst sentiment
Institutional ownership
Screeners with AVIR
FAQ
What is the ticker symbol for Atea Pharmaceuticals, Inc.?
The ticker symbol for Atea Pharmaceuticals, Inc. is NASDAQ:AVIR
Does Atea Pharmaceuticals, Inc. pay dividends?
No, Atea Pharmaceuticals, Inc. does not pay dividends
What sector is Atea Pharmaceuticals, Inc. in?
Atea Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Atea Pharmaceuticals, Inc. in?
Atea Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Atea Pharmaceuticals, Inc. based in?
Atea Pharmaceuticals, Inc. is headquartered in United States
When did Atea Pharmaceuticals, Inc. go public?
Atea Pharmaceuticals, Inc. initial public offering (IPO) was on October 30, 2020
Is Atea Pharmaceuticals, Inc. in the S&P 500?
No, Atea Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Atea Pharmaceuticals, Inc. in the NASDAQ 100?
No, Atea Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Atea Pharmaceuticals, Inc. in the Dow Jones?
No, Atea Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Atea Pharmaceuticals, Inc. last earnings report?
Atea Pharmaceuticals, Inc.'s most recent earnings report was on March 5, 2026
When does Atea Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Atea Pharmaceuticals, Inc. is May 12, 2026
Data Sources & References
- AVIR Official Website ateapharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1593899/000119312526094159/0001193125-26-094159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1593899/000119312526094159/0001193125-26-094159-index.htm
- AVIR Profile on Yahoo Finance finance.yahoo.com/quote/AVIR
- AVIR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avir